Last updated on August 2019

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis


Brief description of study

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.

Clinical Study Identifier: NCT03915964

Find a site near you

Start Over

Tula Regional Clinical Hospital

Tula, Russian Federation
3.38miles
  Connect »